Given Imaging Guides Ingestible Microcapsule Through De Novo Process

Given Imaging hopes to be the second company to have a product cleared by way of FDA's de novo program this year by proposing to include several cautionary statements in the labeling of its wireless endoscopy diagnostic imaging system.

More from Archive

More from Medtech Insight